AKTX
Akari Therapeutics Plc
Going-concern doubt
— flagged May 19, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern for at least a one-year period following the issuance of these condensed consolidated financial statements.”View the 10-Q filed May 19, 2026
Company with tickers: AKTX
CIK
1541157
CUSIP
00972G207
Shares Outstanding
91,567,009,533
13F Activity (30d)
2 filings
1 filers
Quarterly earnings calls grouped as a single event — the transcript, the 8-K earnings release, the quarter's 10-Q or 10-K, and (where available) the audio and slide deck. Each badge shows which artefacts have landed for that quarter.
| Period | Call date | Event | Artefacts | Open |
|---|---|---|---|---|
| FY2025 Q1 | 2025-04-16 | Akari Therapeutics Plc Q1 FY2025 Earnings Call |
Audio
Transcript
Slides
8-K
10-Q
|
|
| FY2024 Q2 | 2024-08-19 | Akari Therapeutics Plc Q2 FY2024 Earnings Call |
Audio
Transcript
Slides
8-K
10-Q
|
|
| FY2024 Q1 | 2024-04-01 | Akari Therapeutics Plc Q1 FY2024 Earnings Call |
Audio
Transcript
Slides
8-K
10-Q
|
Showing 1–3 of 3 earnings calls